Eseng Lai is an Endocrinology/Metabolic physician affiliated with Merck & Co.. OpenAlex indexes 100 publications with 6,713 citations (h-index 36).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingNIH funding
4 NIH research awards on record, funded 1992–2001 per NIH RePORTER. The latest:
- TRANSCRIPTIONAL CONTROL OF MAMMALIAN BRAIN DEVELOPMENT
Sloan-Kettering Institute for Cancer Res
FY2001$320,399R01HD029584 - TRANSCRIPTIONAL CONTROL OF EYE DEVELOPMENT
Sloan-Kettering Institute for Cancer Res
FY2001$279,173R01EY011124 - TRANSCRIPTIONAL CONTROL OF MAMMALIAN BRAIN DEVELOPMENT
Sloan-Kettering Institute for Cancer Res
FY2000$313,690R01HD029584
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Ednan Bajwa, MD
Merck & Co.
Annaswamy Raji, MD
Merck & Co.
Ritu Valiyil, MD
Merck & Co.
William F. Keane
Merck & Co.
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”